Cancer-Associated Intermediate Conductance Ca2+-Activated K+ Channel KCa3.1

by Corinna J. Mohr, Friederike A. Steudel, Dominic Gross, Peter Ruth, Wing-Yee Lo, Reiner Hoppe, Werner Schroth, Hiltrud Brauch, Stephan M. Huber, Robert Lukowski
Published 2019-01-01

Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen

by Werner Schroth, Werner Schroth, Stefan Winter, Stefan Winter, Thomas Mürdter, Thomas Mürdter, Elke Schaeffeler, Elke Schaeffeler, Diana Eccles, Bryony Eccles, Balram Chowbay, Balram Chowbay, Balram Chowbay, Chiea C. Khor, Chiea C. Khor, Chiea C. Khor, Arafat Tfayli, Nathalie K. Zgheib, Michel Eichelbaum, Michel Eichelbaum, Michel Eichelbaum, Matthias Schwab, Matthias Schwab, Matthias Schwab, Matthias Schwab, Hiltrud Brauch, Hiltrud Brauch, Hiltrud Brauch
Published 2017-08-01

The Influences of Adherence to Tamoxifen and CYP2D6 Pharmacogenetics on Plasma Concentrations of the Active Metabolite (Z)‐Endoxifen in Breast Cancer

by Jeanine Marie Nardin, Werner Schroth, Thais Abreu Almeida, Thomas Mürdter, Solane Picolotto, Evelyn Castillo Lima Vendramini, Reiner Hoppe, Jenifer Primon Kogin, Diandra Miqueleto, Silvia Dark Robaskievicz deMoraes, Matthias Schwab, Roberto Flavio Pecoits‐Filho, Hiltrud Brauch, José Claudio Casali‐da‐Rocha
Published 2020-03-01